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Izumi Naka1, Jintana Patarapotikul2, Hathairad Hananantachai2, Hiroo Imai3 and Jun Ohashi1*Abstract
Background: Cytoadhesion of Plasmodium falciparum-infected erythrocytes to endothelial cells in microvessels is a
remarkable characteristic of severe malaria. The endothelial protein C receptor (EPCR), encoded by the endothelial
protein C receptor gene (PROCR), has recently been identified as an endothelial receptor for specific P. falciparum
erythrocyte membrane protein 1 (PfEMP1) subtypes containing domain cassettes (DCs) 8 and 13. The PROCR
rs867186-G allele (serine-to-glycine substitution at position 219 of EPCR; 219Gly) has been shown to be associated
with higher levels of plasma soluble EPCR (sEPCR). In this study, the association of PROCR rs867186 with severe
malaria is examined in Thai population.
Methods: A total of 707 Thai patients with P. falciparum malaria (341 with severe malaria and 336 with mild
malaria) were genotyped for rs867186. To assess the association of PROCR rs867186 with severe malaria, three
models (dominant, recessive and allelic) were evaluated. The rates of non-synonymous and synonymous substitutions
were estimated for the coding sequence of the PROCR gene.
Results: The rs867186-GG genotype was significantly associated with protection from severe malaria (P-value = 0.026;
odds ratio = 0.33; 95% confidence interval = 0.12–0.90). Evolutionary analysis provided no evidence of strong positive
selection acting on the PROCR gene.
Conclusion: The rs867186-GG genotype showed significant association with protection from severe malaria. The
present results suggest that PfEMP1–EPCR interaction, which can mediate cytoadhesion and/or reduce cytoprotective
and anti-inflammatory effects, is crucial to the pathogenesis of severe malaria.Background
The cytoadhesion of Plasmodium falciparum-infected
erythrocytes to endothelial cells in microvessels has been
considered to be involved in the pathogenesis of severe
malaria [1-3]. Several P. falciparum proteins (ligands)
and human endothelial proteins (receptors) associated
with the cytoadhesion have been identified to date [4-7].
The main parasite ligand expressed at the infected
erythrocyte surface is a family of P. falciparum erythro-
cyte membrane protein 1 (PfEMP1) proteins. The PfEMP1
family is encoded by var genes, which are expressed in a
mutually exclusive fashion [8]. The var gene family is clas-
sified into three main subgroups, A, B, and C. PfEMP1 var-
iants encoded by group B and C var genes bind CD36,* Correspondence: juno-tky@umin.ac.jp
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unless otherwise stated.whereas non-CD36 binding variants are encoded by some
group A var genes [9,10]. Recently, the PfEMP1 subtypes
containing domain cassettes (DCs) 8 (group B/A hybrid)
and 13 (group A) are shown to mediate adherence of
P. falciparum-infected erythrocytes to brain endothe-
lial cells [11,12]. A DC8-expressing clonal parasite line
can also bind to primary microvascular cells from
heart, lung, and dermis [11]. In addition, high tran-
scription levels of genes encoding DC8 and DC13 are
reported to be significantly associated with severe
childhood malaria [13]. These observations suggest
that DC8 and DC13 PfEMP1 variants play a key role in
cytoadhesion of P. falciparum-infected erythrocytes to
various endothelial cells. More recently, it has been
demonstrated that the endothelial protein C receptor
(EPCR) acts as an endothelial receptor for DC8 and
DC13 PfEMP1 variants [7]. Of interest, binding tod. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Table 1 Primers used in this study
Product Primer name Primer sequence
PCR 1 PCR 1 F GAGAAGGGAAAAGGCAGGTC
PCR 1 R TGCCTGCCCTGTAGAGAGAT
PCR 2 PCR 2 F CCTCGAGGTAGGGGGTTATT
PCR 2 R CACCCAGCAATCTTCAAAGG
PCR 3 PCR 3 F TCATGTTCTTTTCCCCTTGG
PCR 3 R CCATCCATTTGTCTGGAACC
PCR 4-1 PCR 4–1 F CACACGCAGCTTCAGTCAGT
PCR 4–1 R TCCCATCCCAAGTCTGACAC
PCR 4-2 PCR 4–2 F TGGCCCATCCTCCAAAGACAG
PCR 4–2 R CCAGAAATTTTGCAAAGTGGA
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is significantly higher in parasite isolates from patients
with severe malaria than in those from children with
uncomplicated and mild malaria [7].
EPCR, a 46-kDa type 1 transmembrane glycoprotein,
homologous to major histocompatibility complex class I/
CD1 family proteins, is encoded by the endothelial pro-
tein C receptor gene (PROCR) (OMIM 600646) and is
expressed on endothelial cells [14,15]. Endothelial cell-
bound EPCR is a receptor for protein C and facilitates
the activation of protein C. EPCR also exists as a soluble
form of EPCR (sEPCR), resulting from metalloprotease-
mediated EPCR membrane shedding [16], in human
plasma. In contrast to endothelial cell-bound EPCR,
sEPCR inhibits the activation of protein C by competing
for protein C with endothelial cell-bound EPCR. Inter-
estingly, variations in plasma sEPCR levels are mostly
determined by the genotype of rs867186 (Ser219Gly), a
non-synonymous single nucleotide polymorphism (SNP)
of the PROCR gene [17-24]. The rs867186-G allele is
strongly associated with increased sEPCR levels. The
rs867186-G allele encodes glycine instead of serine at
codon 219, which is located in the transmembrane re-
gion of EPCR. Therefore, rs867186 may also introduce
conformational changes in endothelial cell-bound EPCR.
These observations raise the question of whether the
PROCR rs867186 allele affects the pathogenesis of mal-
aria through changes in the ability of PfEMP1 proteins
with DC8 or DC13 to bind EPCR on endothelial cells. In
this study, the association of rs867186 with severe mal-
aria was examined in Thai adult patients with malaria.
The results indicate that the rs867186-GG genotype is sig-
nificantly associated with protection from severe malaria.
Methods
Subjects
A total of 707 adult patients with P. falciparum malaria
living in Suan Phung, Ratchaburi-Province, Northwest
Thailand were investigated in this study. All the patients
underwent treatment at the Hospital for Tropical Dis-
eases, Faculty of Tropical Medicine, Mahidol University,
Bangkok, Thailand. Malarial infection by P. falciparum
was confirmed in all the patients by a positive blood
smear for the asexual form of P. falciparum. Clinical
manifestations of malaria were classified according to the
definitions and associated criteria of the World Health
Organization. Severe malaria was defined as the presence of
one of the following signs: high parasitaemia (>100,000 para-
sites/ml), hypoglycaemia (glucose level <22 nmol/l), severe
anaemia (haematocrit <20% or haemoglobin level <7 g/dl),
increased serum creatinine (>3 mg/dl), and unrousable
coma caused by malaria infection. Cerebral malaria was de-
fined as the presence of unrousable coma regardless of the
other signs. Mild malaria was defined as having feverwithout other causes of infection and the absence of signs
indicating severe malaria. According to the definition men-
tioned above, 707 adult malaria patients were classified into
341 patients with severe malaria (108 patients with cerebral
malaria and 233 with non-cerebral severe malaria) and 366
with mild malaria. All the individuals were ≥13 years of age,
and the mean age of patients with severe and mild malaria
was 25.4 and 25.8 years, respectively. This study was ap-
proved by the institutional review board of the Faculty of
Tropical Medicine, Mahidol University, and the Research
Ethics Committee of the Graduate School of Comprehen-
sive Human Sciences, University of Tsukuba, Tsukuba,
Ibaraki, Japan. Written informed consent was obtained
from all the patients. Three western chimpanzees (Pan
troglodytes verus) were also investigated.
DNA extraction
Genomic DNA was extracted from the peripheral blood
leukocytes of patients with malaria and from peripheral
blood samples of western chimpanzees using the QIAamp®
DNA Blood Kit (Qiagen GmbH, Hilden, Germany) and the
DNeasy® Blood & Tissue Kit (Qiagen GmbH), respectively.
Sequencing analysis
Variations in the coding region of the PROCR gene were
screened in seven patients with malaria (four with mild
and three with severe malaria) and three western chim-
panzees by direct sequencing. The seven patients with
malaria were randomly selected from all the subjects
studied. Primer sequences designed to cover the entire
coding region of the PROCR gene (NM_006404.3) are
presented in Table 1. Polymerase chain reaction (PCR)
conditions are available upon request. PCR amplification
was performed using the GeneAmp® PCR System 9700
(Applied Biosystems, Foster City, CA, USA) and the
FastStart Taq DNA Polymerase Kit (Roche Molecular
Biochemicals, Mannheim, Germany). PCR products
were sequenced using an ABI Prism® 3100 Genetic
Analyzer (Applied Biosystems).
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The PROCR rs867186 SNP was genotyped using the
TaqMan® SNP genotyping assay.
Statistical analysis
The Fisher’s exact test based on a 2 × 2 table was used to
assess the association of rs867186 with susceptibility to se-
vere malaria. In the association test, three models (domin-
ant, recessive and allelic) with regard to rs867186-G were
examined. The significance level of this study was set to
be 0.05 in two-sided test. The individual genotypes of
SNPs in HapMap-CHB (Han Chinese in Beijing) and
HapMap-JPT (Japanese in Tokyo) populations were re-
trieved from the HapMap database [25,26] and 1,000
genome project database [27], and then pair-wise linkage
disequilibrium (LD) parameters, r2, between PROCR SNPs
were estimated by using Haploview software [28]. The
PolyPhen-2 (Polymorphism Phenotyping v2) software [29]
was used to predict possible impact of the serine-to-
glycine substitution at codon 219 (i e, rs867186-A to -G)
on the structure and function of EPCR. The difference in
transcription factor DNA-binding specificity between two
alleles at each SNP was evaluated using the RegSNP [30],
a web tool for predicting the effect of SNP on transcrip-
tion factor-DNA binding. The number of nucleotide sub-
stitutions per site between two individual sequences was
estimated for the PROCR coding region, based on the
two-parameter method of Kimura [31]. Based on the esti-
mated number of substitutions, a phylogenetic tree was
constructed by using the neighbour-joining method [32]
as implemented in MEGA 5.0 [33]. Tajima’s relative rate
test [34,35] was performed using MEGA 5.0 software [33].
The PROCR mRNA sequences of rhesus macaque
(GenBank Accession No. XM_001100647) was re-
trieved from the GenBank database, and used as an
outgroup sequence. For PROCR coding sequences of
human and chimpanzee, the number of non-synonymous
substitutions per non-synonymous site (dN) and the num-
ber of synonymous substitutions per synonymous site (dS)Figure 1 PROCR single nucleotide polymorphism detected in this stud
CHB subjects and 89 JPT subjects in the 1000 Genomes Project database. T
were detected in a variation screening for seven malaria subjects. The PCR
the PROCR gene (NM_006404.3). The open and shaded boxes indicate UTR
the exon number of the PROCR gene.were estimated using the Nei–Gojobori method with the
Jukes–Cantor model [36]. The variance of (dN − dS) was
estimated using the bootstrap resampling method (1,000
resamplings), and P-value based on Z-test statistics were
calculated using MEGA 5.0 software [33].
Results
Screening for variation
Screening for variation in the entire coding region of
PROCR detected one non-synonymous SNP (rs867186
[Ser219Gly]) in exon 4 and one SNP (rs9574) in 3′UTR
in seven Thai patients with malaria, which suggests that
there was no common non-synonymous SNP other than
rs867186 in the Thai population. To confirm this, poly-
morphisms of the PROCR gene in Asian populations
were searched using the 1000 Genomes Project database
[27]. In addition to rs867186 and rs9574, 21 PROCR
SNPs were polymorphic in a sample set of 97 CHB sub-
jects and 89 JPT subjects: one SNP in 5′UTR and 20
SNPs in introns (Figure 1). Of 23 SNPs detected in the
1000 Genomes Project database, 10 SNPs (rs867186,
rs9574, and eight intronic SNPs) had a minor allele fre-
quency of >0.05. Each of these eight intronic SNPs was
tagged by either rs867186 or rs9574 with an r2 threshold
of 0.8. These results suggest that the PROCR gene has
only one common non-synonymous SNP, rs867186, and
exhibits limited haplotype diversity in Asian populations.
Thus, in this present study, rs867186, which has been
shown to have functional significance [17-24], was
investigated.
Association test
The genotype frequencies of rs867186 in patients with
malaria are shown in Table 2. A comparison of the nu-
cleotide sequence of human PROCR with that of the
western chimpanzee indicated that rs867186-G (219Gly)
is a derived allele (a point mutation that occurred in the
human lineage). Therefore, the direction of association
was determined by rs867186-G. Table 3 shows the resultsy. A total of 23 PROCR SNPs were polymorphic in a sample set of 97
wo SNPs (rs867186 [Ser219Gly] and rs9574) indicated by solid lines
fragments investigated in this study are shown below the structure of
and coding regions, respectively. The numbers in the boxes indicate
Table 2 Genotype frequencies of rs867186 in Thai
malaria patients
Genotype Severe malaria Mild malaria
n (frequency) n (frequency)
GG 5 (0.015) 16 (0.044)
GA 94 (0.276) 88 (0.240)
AA 242 (0.710) 262 (0.716)
1
0.8
0.6
0.4
0.2
0
r2
rs867186
0
0.2
0.4
0.6
0.8
1
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CPNE1
ERGIC3
CEP250
GEF5
UQCC
MMP24
SPAG4
EPCREDEM2
TRPC4AP
MYH7B
GSS
ACSS2
GGT7NCOA6
Figure 2 Plot of linkage disequilibrium between rs867186 and
nearby single nucleotide polymorphism. LD coefficient r2
between rs867186 and each of 553 SNPs with minor allele frequency
of more than 0.03 in the HapMap-CHB and -JPT populations were
plotted. Each plot is coloured based on the value of r2.
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recessive and allelic). A recessive model (rs867186-GG
versus rs867186-AG and rs867186-AA) showed a statisti-
cally significant difference in genotype frequency between
patients with severe and mild malaria (P-value = 0.026;
odds ratio [OR] = 0.33; 95% confidence interval [CI] =
0.12–0.90). Thus, rs867186-GG was associated with pro-
tection from severe malaria.
In silico analysis of rs867186
A serine-to-glycine substitution at codon 219 of EPCR
(i e, from rs867186-A to rs867186-G) was predicted to
be “benign”, with a score of 0.201, by PolyPhen-2 soft-
ware. Although rs867186-G was statistically associated
with protection from severe malaria, rs867186 may not
be an SNP primarily associated with severe malaria. In
other words, the significant association of rs867186
with severe malaria may come from LD between
rs867186 and a causative SNP. Analysis of LD detected
ten SNPs in strong LD (r2 ≥ 0.8) with rs867186 in
Asian populations (HapMap-CHB + JPT; Figure 2). Of
these, six SNPs, rs6120843, rs1033797, rs1033799,
rs11908683, rs2295888, and rs11907010, are located in
the genomic region of the endoplasmic reticulum (ER)
degradation enhancer, mannosidase alpha-like 2 gene
(EDEM2; Figure 2). EDEM2 is involved in the ER-
associated degradation of glycoproteins [37]. Because
EDEM2 does not appear to be involved in malaria
pathogenesis, the six EDEM2 SNPs would not be pri-
marily associated with severe malaria. The other four
SNPs were located closer to the PROCR gene. Two of
these, rs8119351 and rs2069940, are located in the up-
stream region of PROCR. However, no difference in
transcription factor–DNA-binding specificity between
two alleles at each of these SNPs was predicted by
RegSNP [30]. The remaining two SNPs, rs11167260 and
rs17092456, are located more than 10 kb downstream ofTable 3 Association of rs867186 with severe malaria
Model P-value OR 95% CI
Dominant (GG + GA vs AA) 0.87 1.03 0.74-1.43
Recessive (GG vs GA + AA) 0.026 0.33 0.12-0.90
Allele (G vs A) 0.56 0.92 0.69-1.22
The P-value was calculated by Fisher’s exact test.the coding region of PROCR; thus, these SNPs are unlikely
to affect its transcription.
Evolutionary analysis
A phylogenetic tree was constructed on the basis of the
estimated number of nucleotide substitutions in the cod-
ing region of PROCR (Additional file 1). A comparison
of human, chimpanzee and macaque sequences sug-
gested that a synonymous substitution had been fixed in
the human lineage after the divergence between humans
and chimpanzees, whereas four substitutions (three non-
synonymous and one synonymous) had been fixed in the
western chimpanzee lineage (Additional file 2). To exam-
ine whether the substitution rate is different between hu-
man and chimpanzee, Tajima’s relative rate test was
performed. The result revealed no significant difference in
the nucleotide substitution rate between humans and
chimpanzees.
The observation that EPCR acts as a receptor for
DC8 and DC13 PfEMP1 [7] raises the question of
whether the human PROCR gene has been subjected to
positive selection. An excess in the non-synonymous
substitution rate relative to the synonymous rate when
compared to neutral expectations is regarded as the
signature of positive selection. To assess the possibility
of natural selection acting on PROCR after the diver-
gence between humans and chimpanzees, the number
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site and the number of synonymous substitutions per
synonymous site were calculated for the human and
chimpanzee coding sequences of PROCR. The rate of
non-synonymous substitution (dN = 0.006 for 219Ser
and dN = 0.008 for 219Gly) did not significantly differ
from that of synonymous substitution (dS = 0.011), sug-
gesting that PROCR has not been under strong positive se-
lection. It is noted here that the values of dN were
calculated for human PROCR bearing 219Ser and 219Gly,
separately.
Discussion
The PROCR rs867186 was significantly associated with
severe malaria in Thai adult patients. There are two pos-
sible explanations for the association of rs867186-GG with
protection from severe malaria. The serine-to-glycine sub-
stitution at codon 219 in the transmembrane of EPCR
may introduce a conformational change in the molecule,
which prevents DC8 and DC13 PfEMP1 from binding
EPCR. The rs867186-G is associated with higher levels of
sEPCR [17-24], and the addition of recombinant sEPCR
inhibits the binding between DC8-expressing parasites
and human brain microvascular endothelial cells [7];
therefore, the other possible explanation is that higher
levels of sEPCR in malaria patients with the rs867186-GG
genotype cause greater inhibition of the binding of DC8
and DC13 PfEMP1 to EPCR on endothelial cells through
preferential binding of DC8 and DC13 PfEMP1 to sEPCR
compared with EPCR. In this case, malaria patients with
the rs867186-GG genotype may efficiently block the
cytoadhesion of P. falciparum-infected erythrocytes to the
endothelial cells of microvessels. In addition, if DC8 and
DC13 PfEMP1 variants are more likely to bind sEPCR
than protein C, more protein C may be allowed to bind
EPCR on endothelial cells in malaria patients with the
rs867186-GG genotype than in those with the other geno-
types. Binding of protein C to EPCR leads to the activation
of protein C. Activated protein C exerts cytoprotective
and anti-inflammatory effects, which may contribute to
protection against severe malaria [7], including cerebral
malaria [38].
EPCR binding is significantly higher in parasite isolates
from African children with severe malaria than in those
from children with uncomplicated and mild malaria [7],
suggesting that binding of PfEMP1 to EPCR may be a
common risk factor of severe malaria regardless of its
form. Cerebral malaria, a form of severe malaria that in-
volves encephalopathy, is considered to be caused by ex-
cessive adherence of P. falciparum-infected erythrocytes
to the microvasculature of the brain. In this study,
among 341 severe malaria patients, 108 patients had suf-
fered from cerebral malaria. When patients with severe
malaria were divided into two groups: 108 patients withcerebral malaria and 233 patients with non-cerebral se-
vere malaria, rs867186-GG was found to be significantly
associated with protection from non-cerebral severe
malaria (P-value = 0.014; OR = 0.19; 95% CI = 0.04–
0.83), but not with cerebral malaria (P-value = 0.59;
OR = 0.63; 95% CI = 0.18–2.19) (Additional file 3). The
lack of association with cerebral malaria may have resulted
from the small sample size (i.e., 108 cerebral malaria pa-
tients), since the direction of association observed for
cerebral malaria was same as non-cerebral severe malaria
(i.e., ORs for cerebral malaria and non-cerebral severe
malaria were smaller than 1). In addition, misclassification
of cerebral malaria (i.e., some cerebral malaria patients
may have had coma without cerebral sequestration)
may have reduced the statistical power of the present
study. Considering the accumulated evidence that the
DC8 and DC13 PfEMP1 variants mediate adherence of
P. falciparum-infected erythrocytes to brain endothe-
lial cells [11,12], the possibility of rs867186-GG being
associated with protection from cerebral malaria should
not be excluded. Studies with a larger number of cerebral
malaria patients will be needed to examine the possible as-
sociation of rs867186 with cerebral malaria.
If the binding of DC8 and DC13 PfEMP1 to EPCR on
brain endothelial cells plays a crucial role in cerebral
malaria, lower expression of EPCR is expected to de-
crease the risk for cerebral malaria. However, a recent
study has shown that endothelial EPCR expression is sig-
nificantly decreased in cerebral blood vessels from Mala-
wian children with cerebral malaria characterized by
sequestration of P. falciparum-infected erythrocytes than
in controls characterized by absence of P. falciparum-
infected erythrocyte sequestration [39]. To further under-
stand the role of EPCR in the pathogenesis of cerebral
malaria, levels of endothelial expression of cell-bound and
soluble forms of EPCR are required to be compared be-
tween cerebral and mild malaria patients, after adjustment
for rs867186 genotype and expression levels of DC8 and
DC13 PfEMP1 variants.
No evidence of positive selection was found in the
evolutionary analysis based on the comparison of dN
with dS. There are a few possible explanations: the first
is that the statistical power was low. Only five substitu-
tions had been fixed either in the human lineage or in
the chimpanzee lineage after the divergence between
them. The second is that the number of target sites (co-
dons) of positive selection may be small. If most sites are
under purifying selection, it would not be possible to de-
tect the significant difference between dN with dS in the
entire coding region. The third is that PfEMP1 subtypes
containing DC8 and DC13 may have appeared recently in
P. falciparum and advantageous mutations that help to es-
cape from the binding of DC8 and DC13 PfEMP1 to
EPCR have not occurred yet in human PROCR.
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Additional file 1: A phylogenetic tree of PROCR. Based on the
estimated number of nucleotide substitutions, a phylogenetic tree of 14
human sequences, six western chimpanzee sequences, and a macaque
sequence of the coding region of PROCR was constructed using the
neighbour-joining method. The scale bar indicates nucleotide substitutions
per site.
Additional file 2: Multiple sequence alignment of the coding region
of PROCR.
Additional file 3: Genotype frequencies of rs867186 in cerebral,
non-cerebral severe, and mild malaria patients.
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